CompletedNCT04308928
Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis
Studying OBSOLETE: Tuberculous meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Stellenbosch
- Principal Investigator
- Novel Chegou, ProfUniversity of Stellenbosch
- Enrollment
- 332 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 2020 – 2025
Study locations (1)
- Stellenbosch University Immunology Research Group, Cape Town, Western Cape, South Africa
Collaborators
European and Developing Countries Clinical Trials Partnership (EDCTP) · Medical Research Council, South Africa
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04308928 on ClinicalTrials.govOther trials for OBSOLETE: Tuberculous meningitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05383742Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous MeningitisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT05590455Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisANRS, Emerging Infectious Diseases